KICVentures acquired Amend Surgical, a company developing synthetic bioactive glass products.
Here are five insights:
1. Amend Surgical's portfolio also includes an FDA-cleared demineralized bone matrix and bioactive glass combination.
2. The acquisition will boost KICVentures' NanoFuse Biologics company.
3. During the transition, Amend Surgical will manufacture the NanoFuse Bioactive Matrix.
4. The NanoFuse Bioactive Matrix combines osteoinductive capabilities of demineralized bone with osteostimulative properties of bioactive glass.
5. Orthopedic surgeon Kingsley R. Chin, MD, founded KICVentures, a private investment company, in 2005.